IL116228A0 - Monoclonal antibody fragments and pharmaceutical compositions containing them - Google Patents

Monoclonal antibody fragments and pharmaceutical compositions containing them

Info

Publication number
IL116228A0
IL116228A0 IL11622895A IL11622895A IL116228A0 IL 116228 A0 IL116228 A0 IL 116228A0 IL 11622895 A IL11622895 A IL 11622895A IL 11622895 A IL11622895 A IL 11622895A IL 116228 A0 IL116228 A0 IL 116228A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
monoclonal antibody
compositions containing
antibody fragments
fragments
Prior art date
Application number
IL11622895A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL116228A0 publication Critical patent/IL116228A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11622895A 1994-12-07 1995-12-01 Monoclonal antibody fragments and pharmaceutical compositions containing them IL116228A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07

Publications (1)

Publication Number Publication Date
IL116228A0 true IL116228A0 (en) 1996-03-31

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11622895A IL116228A0 (en) 1994-12-07 1995-12-01 Monoclonal antibody fragments and pharmaceutical compositions containing them

Country Status (19)

Country Link
EP (1) EP0787151A1 (pt)
JP (1) JP2001506122A (pt)
CN (1) CN1168679A (pt)
AR (1) AR002005A1 (pt)
AU (1) AU4256096A (pt)
BR (1) BR9509902A (pt)
CA (1) CA2206471A1 (pt)
CO (1) CO4480041A1 (pt)
CZ (1) CZ172497A3 (pt)
FI (1) FI972430A7 (pt)
HU (1) HUT77342A (pt)
IL (1) IL116228A0 (pt)
MA (1) MA23739A1 (pt)
NO (1) NO972522L (pt)
PE (1) PE52996A1 (pt)
PL (1) PL320610A1 (pt)
TR (1) TR199501542A2 (pt)
WO (1) WO1996017874A1 (pt)
ZA (1) ZA9510195B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
ATE365749T1 (de) * 2000-05-12 2007-07-15 Gpc Biotech Ag Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US20030086929A1 (en) 2001-10-11 2003-05-08 Tso J. Yun Treatment of prostate cancer by inhibitors of ATP synthase
EP1369431A4 (en) 2001-10-15 2005-01-12 Kirin Brewery ANTI-HLA-DR ANTIBODIES
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2552483A4 (en) * 2010-04-01 2013-09-25 Immunomedics Inc USE OF ANTIBODIES TO REDUCE THE NUMBER OF CELLS CONTAINING ANTIGENS AND DENDRITIC CELLS
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
JPH05502586A (ja) * 1989-12-27 1993-05-13 セントカー・インコーポレーテツド Ｃｄ４受容体に対するキメラ免疫グロブリン
NZ243706A (en) * 1991-07-25 1994-08-26 Idec Pharma Corp Recombinant monkey antibodies, pharmaceutical compositions

Also Published As

Publication number Publication date
NO972522L (no) 1997-08-06
MX9704225A (es) 1997-09-30
TR199501542A2 (tr) 1996-07-21
BR9509902A (pt) 1997-10-21
FI972430L (fi) 1997-06-06
PL320610A1 (en) 1997-10-13
AR002005A1 (es) 1998-01-07
PE52996A1 (es) 1996-12-12
ZA9510195B (en) 1996-06-07
EP0787151A1 (en) 1997-08-06
CO4480041A1 (es) 1997-07-09
CZ172497A3 (en) 1997-10-15
MA23739A1 (fr) 1996-07-01
WO1996017874A1 (en) 1996-06-13
FI972430A0 (fi) 1997-06-06
FI972430A7 (fi) 1997-06-06
NO972522D0 (no) 1997-06-03
AU4256096A (en) 1996-06-26
CA2206471A1 (en) 1996-06-13
CN1168679A (zh) 1997-12-24
HUT77342A (hu) 1998-03-30
JP2001506122A (ja) 2001-05-15

Similar Documents

Publication Publication Date Title
IL122370A0 (en) Monkey monoclonal antibodies and pharmaceutical compositions containing them
IL99363A0 (en) Pharmaceutical compositions comprising homoconjugated monoclonal antibodies
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
ZA9510806B (en) Anti-xv-integrin monoclonal antibody
PL314908A1 (en) Humanised antibodies and their application
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
ZA964733B (en) Ob protein compositions and methods
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL118221A0 (en) Substituted cephalosporins and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL114673A0 (en) Pharmaceutical compositions containing protein
HUP9904199A3 (en) Anti-p53 single-chain antibody fragments and their uses
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
EP0909278A4 (en) IMMUNOGLOBULIN G LINKED TO NEPHROPATHY AND ANTIBODIES AGAINST IT
ZA9510195B (en) Monoclonal antibody fragments having immunosuppressant activity
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL118407A0 (en) Polymyxin dextran conjugates their preparation and pharmaceutical compositions containing them
IL115882A0 (en) Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them
SI1068241T1 (sl) Protitelesne variante in njihovi fragmenti
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
EP0513778A3 (en) Hybrid monoclonal antibodies and compositions containing them
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them